← Back to all trials
Recruiting
NCT02300766
Cerebellar Mutism Syndrome Study
Conditions: Infratentorial Neoplasms, Mutism
Sex: All
Ages: N/A – 18 Years
Healthy volunteers: No
Enrollment: 2000
Sponsor: Rigshospitalet, Denmark
Location: Medical University of Vienna Vienna
Summary
The purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the purpose is to explore the clinical course and the best treatment of the syndrome.
Eligibility Criteria
Inclusion Criteria:
* Age \< 18 years at the date of first imaging showing this tumour
* Tumour in the cerebellum/4th ventricle/brainstem with intention to treat with surgical resection or open biopsy. Second and further surgeries are also included.
* Informed consent from custodial parent(s)
Exclusion Criteria:
* None
Source: ClinicalTrials.gov (NCT02300766). StuddyBuddy aggregates publicly available trial information.
